Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00HPD
|
||||
Former ID |
DNCL003374
|
||||
Drug Name |
Moxetumomab pasudotox
|
||||
Synonyms |
CAT-8015; GCR-8015; HA22
|
||||
Drug Type |
Monoclonal antibody
|
||||
Indication | Haematological malignancies [ICD9: 200-209; ICD10:C81-C86] | Phase 1 | [551581] | ||
Therapeutic Class |
Anticancer Agents
|
||||
Company |
AstraZeneca
|
||||
Target and Pathway | |||||
Target(s) | B-cell receptor CD22 | Target Info | Modulator | [531663] | |
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
WikiPathways | B Cell Receptor Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.